Skip to main content
. 2016 Apr 6;46(9):1909–1921. doi: 10.1017/S0033291716000398

Table 3.

Side effects and safety measures

Omnibus test
Variable Baseline (n = 52) Memantine 1 (n = 25) Placebo 1 (n = 24) After wash-out (n = 44) Memantine 2 (n = 21) Placebo 2 (n = 24) χ2/F p
Memantine-related AE mycosis, n (%) χ24 = 5.750 0.33
None 46 (67.3) 23 (92) 20 (83.3) 35 (81.4) 12 (57.1) 22 (88.5)
Very little 2 (3.8) 0 (0.0) 3 (12.5) 3 (7.0) 6 (28.6) 1 (4.2)
Little 4 (7.7) 2 (7.7) 1 (4.2) 4 (9.3) 2 (9.5) 1 (4.2)
Much 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.3) 0 (0.0) 0 (0.0)
Very much 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.8) 0 (0.0)
Memantine-related AE dyspnea, n (%) χ25 = 5.329 0.26
None 26 (50.0) 9 (36.0) 15 (62.5) 19 (43.2) 11 (52.4) 9 (37.5)
Very little 6 (11.5) 10 (16.0) 5 (20.8) 8 (18.2) 5 (23.8) 4 (16.7)
Little 13 (25.0) 4 (40.0) 3 (12.5) 14 (31.8) 4 (19.0) 8 (33.3)
Much 6 (11.5) 0 (0.0) 1 (4.2) 0 (0.0) 0 (0.0) 3 (12.5)
Very much 1 (1.9) 2 (8.0) 0 (0.0) 2 (4.5) 1 (4.8) 0 (0.0)
Mean LUNSERS scores (s.d.)a
Extrapyramidal symptoms 13.37 (4.06) 13.08 (4.18) 13.33 (5.31) 12.34 (3.94) 13.00 (4.30) 12.46 (3.12) F1,182 = 1.598 0.21
Anticholinergic side effects 9.87 (3.46) 9.13 (3.66) 9.92 (3.67) 9.26 (3.04) 9.80 (3.86) 8.33 (2.79) F1,185 = 1.323 0.25
Other autonomic side effects 9.27 (3.16) 8.42 (3.28) 9.33 (3.69) 8.95 (2.85) 9.11 (3.04) 8.37 (2.50) F1,184 = 0.319 0.57
Allergic reactions 5.57 (1.66) 5.17 (1.83) 6.26 (2.49) 6.58 (2.99) 6.70 (3.01) 591 (2.52) F1,180 = 4.839 0.03
Psychic side effects 23.63 (6.34) 22.36 (7.40) 24.58 (6.90) 22.44 (7.42) 22.75 (7.00) 22.08 (7.11) F1,183 = 1.295 0.26
Hormonal side effects 8.20 (3.03) 7.96 (2.22) 8.33 (2.22) 8.54 (2.68) 8.72 (3.12) 7.38 (2.27) F1,178 = 0.066 0.80
Miscellaneous side effects 6.43 (1.95) 6.54 (2.19) 6.96 (1.76) 6.86 (2.04) 7.37 (1.80) 6.83 (2.10) F1,184 = 1.694 0.20
Red herrings 14.52 (4.72) 14.83 (4.35) 14.92 (4.49) 15.14 (4.94) 15.65 (5.21) 14.78 (4.73) F1,185 = 0.801 0.37
Red herrings ⩾20 0.13 (0.35) 0.17 (0.38) 0.21 (4.95) 0.21 (0.41) 0.20 (0.41) 0.17 (0.39) F1,184 = 0.446 0.51
Total 92.80 (21.061) 90.9 (23.95) 95.74 (0.12) 93.63 (23.27) 96.00 (27.27) 87.50 (21.94) F1,184 = 0.041 0.84
Total without red herring items 78.41 (17.12) 75.95 (20.16) 80.70 (20.47) 78.69 (19.37) 80.43 (21.96) 72.85 (17.66) F1,161 = 0.447 0.73
Laboratory measurement
Mean clozapine plasma level, ng/ml (s.d.) 421.27 (224.61) 515.16 (240.43) 376.48 (185.11) 461.71 (219.61) 403.06 (179.90) 436.14 (157.07) F1,178 = 1.387 0.24
Range, ng/ml 50–878 101–1060 52–671 60–1080 135–682 200–715
Physical examination
Mean waist circumference, cm (s.d.) 110.04 (13.82) 108.32 (14.71) 104.04 (11.72) 105.50 (13.89) 104.41 (12.16) 107.88 (14.86) F1,181 = 1.205 0.27
Mean systolic blood pressure, mmHg (s.d.) 134.57 (18.77) 169.00 (170.28) 130.26 (12.59) 130.48 (15.94) 125.68 (12.82) 130.75 (11.84) F1,188 = 1.954 0.16
Mean diastolic blood pressure, mmHg (s.d.) 88.00 (9.77) 86.72 (10.57) 87.04 (8.10) 85.95 (9.41) 86.14 (9.70) 83.88 (7.60) F1,188 = 1.084 0.30

AE, Adverse event; LUNSERS, Liverpool University Neuroleptic Side-Effect Rating Scale; s.d., standard deviation.

a Extrapyramidal symptoms: items 19, 29, 34, 37, 40, 43, 48; anticholinergic side effects: items 6, 10, 32, 38, 51; other autonomic side effects: items 15, 16, 20, 27, 36; allergic reactions: items 1, 35, 47, 49; psychic side effects: items 2, 4, 9, 14, 18, 21, 23, 26, 31, 41; hormonal side effects: items 7, 13, 17, 24, 46, 50; miscellaneous side effects: items 5, 12, 39, 44; red herrings: items 3, 8, 11, 12, 25, 28, 30, 33, 42, 45.